Ireland· IE-PA-EU/1/15/1065/002
Eptifibatide Accord 2 mg/ml solution for injection
A eptifibatide product containing eptifibatide, registered in Ireland by Accord Healthcare S.L.U.. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Eptifibatide is registered in 15 of 19 countries.
Countries holding a registration under ATC B01AC16 (eptifibatide), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Eptifibatide · ATC B01AC16
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Eptifibatide
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Ireland (IE)
- ATC code
- B01AC16
- ATC class
- Eptifibatide
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/15/1065/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for eptifibatide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eptifibatide · interactions on record
203 records
- 62 severe
- 76 moderate
- 65 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eptifibatide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesEptifibatideMylan Institutional LLC
- FinlandEptifibatide AccordAccord Healthcare S.L.U.
- United KingdomEptifibatide 20mg/10ml solution for injection vialsMorningside Healthcare Ltd
- SwedenEptifibatide Accord 0,75 mg/ml Infusionsvätska, lösningAccord Healthcare S.L.U.
- FranceEPTIFIBATIDE ACCORD 0,75 mg/ml, solution pour perfusionACCORD HEALTHCARE (ESPAGNE)
- PolandEptifibatide AccordAccord Healthcare S.L.U.
- NetherlandsEptifibatide Accord 0,75 mg/ml oplossing voor infusieAccord Healthcare S.L.U.
- BelgiumEptifibatide Accord 0.75 mg/mlAccord Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Bulgaria · Ептифибатид Ромфарм
- Germany · Eptifibatid, Eptifibatid Altamedics
- Denmark · Eptifibatide "ctruz"
- Finland · Eptifibatide Ctruz
- United Kingdom (Northern Ireland) · Eptifibatide Kensington Pharma
- Hungary · Eptifibatide Rompharm
- Iceland · Eptifibatide Accord
- Italy · Eptifibatide Alida
- Liechtenstein · Eptifibatide Accord
- Netherlands · Eptifibatide Aftpharm
- Norway · Eptifibatide Accord, Eptifibatide Ctruz
- Romania · Eptifibatidă Rompharm
- Sweden · Eptifibatide Ctruz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9df36b30-0259-4a09-8a46-3a61d2ea4511 GET /v1/drugs/9df36b30-0259-4a09-8a46-3a61d2ea4511?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B01AC",
"B01AC16"
],
"strength": null,
"pa_number": "EU/1/15/1065/002",
"substances": [
"Eptifibatide"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "11/01/2016",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about eptifibatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.